BioLineRx (BLRX) Retained Earnings (2012 - 2025)

BioLineRx's Retained Earnings history runs 14 years deep, the most recent figure standing at -$1.4 million for Q4 2025.

• In Q4 2025, Retained Earnings changed 0.0% year-over-year to -$1.4 million; the TTM figure through Dec 2025 stood at -$1.4 million (changed 0.0% YoY), while the FY2025 annual figure was -$1.4 million, changed 0.0% from the prior year.
• Retained Earnings was -$1.4 million for Q4 2025 at BioLineRx, roughly flat from -$1.4 million in the prior quarter.
• In the past five years, Retained Earnings ranged from a high of -$1.4 million in Q1 2021 to a low of -$1.4 million in Q1 2021.
• Historically, Retained Earnings has averaged -$1.4 million across 5 years, with a median of -$1.4 million in 2021.
• Biggest YoY gain for Retained Earnings was 0.0% in 2021; the steepest drop was 0.0% in 2021.
• A 5-year view of Retained Earnings shows it stood at -$1.4 million in 2021, then changed by 0.0% to -$1.4 million in 2022, then changed by 0.0% to -$1.4 million in 2023, then changed by 0.0% to -$1.4 million in 2024, then changed by 0.0% to -$1.4 million in 2025.
• The last three Retained Earnings figures came in at -$1.4 million (Q4 2025), -$1.4 million (Q3 2025), and -$1.4 million (Q2 2025), per Business Quant data.